Liquidia Corporation

IPO

Just breathe

Public · Morrisville, United States · Founded 2004 · $20.0M raised

Employees
51–200
Founded
2004
Business Model
B2B
Total Funding
$20.0M
Last Round
$20.0M Venture RoundJun 2025
Rounds
7
Type
Public

About

Liquidia Corporation is a publicly traded biopharmaceutical company focused on developing and commercializing innovative therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension (PAH). The company leverages its proprietary PRINT nanotechnology platform to engineer inhaled therapies with enhanced efficacy and tolerability. Liquidia trades on Nasdaq as LQDA and is headquartered in Morrisville, North Carolina.

Summary

Liquidia Corporation is a Biotech company based in Morrisville, United States, founded in 2004. It has raised $20.0M in total across 7 rounds, most recently a $20.0M Venture Round round in Jun 2025. Investors include New Enterprise Associates, Healthcare Royalty Partners and Patient Square Capital.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Venture RoundVenture RoundJun 2025

Sign up to see all 7 rounds

Venture Round — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Liquidia Corporation on Indexed.vc
<a href="https://indexed.vc/companies/liquidia-corporation"><img src="https://indexed.vc/api/badge/company/liquidia-corporation" alt="Liquidia Corporation on Indexed.vc" width="260" height="76" /></a>